Lexeo Therapeutics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference

Lexeo Therapeutics (Nasdaq:LXEO) will participate in a fireside chat at the 2026 RBC Capital Markets Global Healthcare Conference on Tuesday, May 19, 2026, at 2:35 p.m. ET in New York.

Rhea-AI Summary

Lexeo Therapeutics (Nasdaq:LXEO) will participate in a fireside chat at the 2026 RBC Capital Markets Global Healthcare Conference on Tuesday, May 19, 2026, at 2:35 p.m. ET in New York.

The event will be webcast live with a replay available on Lexeo’s investor website.

Argus May 19 session

-4.88% close to close Open Argus

Details

News Market Reaction – LXEO

On May 19, the day this news came out, LXEO closed 4.88% below the previous close.

Data tracked by StockTitan Argus for the May 19 session.

Market Context

This announcement focuses on Lexeo’s participation in the 2026 RBC Capital Markets Global Healthcare...

Analysis

This announcement focuses on Lexeo’s participation in the 2026 RBC Capital Markets Global Healthcare Conference, with a fireside chat on May 19, 2026 at 2:35 p.m. ET. It continues a pattern of conference visibility alongside recent earnings and pipeline updates that previously moved the stock. Investors may watch for any incremental commentary on LX2006, LX2020, cash runway into 2028, and how management frames development priorities and capital needs during the event webcast.

Key Figures

Conference year: 2026 Conference date: May 19, 2026 Presentation time: 2:35 p.m. ET

Conference year

2026

RBC Capital Markets Global Healthcare Conference 2026

Conference date

May 19, 2026

Scheduled fireside chat in New York, NY

Presentation time

2:35 p.m. ET

Scheduled start time of Lexeo fireside chat

Historical Context

5 past events · Latest: May 11

5 events

1. May 11

   Q1 2026 earnings

   24h Move

   +5.0%

   Q1 2026 results with positive LX2006/LX2020 data and strong cash runway.

2. Apr 27

   Scientific meeting data

   24h Move

   +3.3%

   Multiple ASGCT presentations highlighting cardiac gene therapy and manufacturing advances.

3. Mar 30

   FY 2025 earnings

   24h Move

   +8.9%

   FY 2025 update with FDA comparability approval, positive interim data and $246.6M cash.

4. Mar 03

   Investor conference

   24h Move

   -0.8%

   Announcement of participation in Leerink Global Healthcare Conference fireside chat.

5. Feb 05

   Investor conferences

   24h Move

   -5.2%

   February 2026 Guggenheim and Oppenheimer investor conference fireside chats.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

NEW YORK, May 19, 2026 (GLOBE NEWSWIRE) -- Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company dedicated to pioneering novel treatments for cardiovascular diseases, today announced that the Company will participate in a fireside chat at the 2026 RBC Capital Markets Global Healthcare Conference on Tuesday, May 19, 2026 at 2:35 p.m. ET in New York, NY.

The event will be webcast live under the News & Events tab in the Investors section of the Company’s website. A replay of the webcast will be available on the Lexeo website following the presentation.

About Lexeo Therapeutics
Lexeo Therapeutics is a New York City-based, clinical stage genetic medicine company dedicated to reshaping heart health by applying pioneering science to fundamentally change how cardiovascular diseases are treated. The company is advancing a portfolio of therapeutic candidates that take aim at the underlying genetic causes of conditions, including LX2006 in Friedreich ataxia (FA) cardiomyopathy, LX2020 in plakophilin-2 (PKP2) arrhythmogenic cardiomyopathy, and others in devastating diseases with high unmet need.

Media Response:
Media@lexeotx.com

Investor Response:
Ashley Kaplowitz
akaplowitz@lexeotx.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Lexeo Therapeutics (LXEO) present at the 2026 RBC Capital Markets Global Healthcare Conference?

Lexeo Therapeutics will present a fireside chat on May 19, 2026, at 2:35 p.m. ET. According to Lexeo, the session takes place in New York and targets investors following its genetic medicine pipeline.

How can investors watch Lexeo Therapeutics’ 2026 RBC healthcare conference webcast?

Investors can watch the Lexeo Therapeutics webcast live via the News & Events tab in the Investors section of its website. According to Lexeo, a replay will also be available online after the presentation concludes.

Will a replay of Lexeo Therapeutics’ 2026 RBC Capital Markets conference fireside chat be available?

Yes, a replay of Lexeo Therapeutics’ fireside chat will be available on the company’s website. According to Lexeo, investors can access it under the Investors section following the live webcast event.

What type of company is Lexeo Therapeutics (Nasdaq:LXEO) presenting at the 2026 RBC healthcare conference?

Lexeo Therapeutics is a clinical-stage genetic medicine company focused on cardiovascular diseases. According to Lexeo, its participation at the 2026 RBC Capital Markets Global Healthcare Conference highlights its ongoing development efforts and engagement with the healthcare investment community.

Where will Lexeo Therapeutics’ 2026 RBC Capital Markets Global Healthcare Conference session take place?

The Lexeo Therapeutics fireside chat will occur in New York, New York, on May 19, 2026. According to Lexeo, the event is part of the RBC Capital Markets Global Healthcare Conference and will be accessible via live webcast.